https://doi.org/10.1210/en.2013-1977
B
Barry S. Komm
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
192
Papers
13.5K
Citations
59
h-index
121
i10-index
Barry S. Komm is an academic researcher from Vifor Pharma (United States). The author has contributed to research in topics: Estrogen and related hormone effects & Menopause: Health Impacts and Treatments & Bone Metabolism and Diseases. The author has an h-index of 59, co-authored 164 publications.
Papers by this author
worksEndometriosis Impairs Bone Marrow-Derived Stem Cell Recruitment to the Uterus Whereas Bazedoxifene Treatment Leads to Endometriosis Regression and Improved Uterine Stem Cell Engraftment
2014 · Endocrinology · 88 citations
Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes
2014 · Breast Cancer Research · 20 citations
https://doi.org/10.1186/bcr3677
Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancer
2024 · Breast Cancer Research · 8 citations
https://doi.org/10.1186/s13058-024-01843-4
Most bothersome symptom in women with genitourinary syndrome of menopause as a moderator of treatment effects
2016 · Menopause The Journal of The North American Menopause Society · 7 citations
https://doi.org/10.1097/gme.0000000000000679
Overcoming challenges in conducting early phase breast cancer prevention trials: Bazedoxifene and conjugated estrogens vs waitlist control
2024 · Contemporary Clinical Trials · 0 citations
https://doi.org/10.1016/j.cct.2024.107697
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat